In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7

Qingxian Zhang, Yonghong Shi, Jun Wada et al. · 2010

Read In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7 by Qingxian Zhang, Yonghong Shi, Jun Wada et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011709.txt.

Description

Qingxian Zhang and co-authors tested a gene-silencing treatment for diabetic kidney disease, in PLOS ONE in 2010. Diabetic nephropathy is complex and poorly understood, and current treatments are limited. A developmental protein called gremlin, which blocks helpful bone morphogenetic proteins, had emerged as a suspect driver of the damage.

The team delivered RNA designed to silence gremlin into living animals. Silencing it restored levels of the protective protein BMP-7 and eased the kidney disease. The result in a living system marks gremlin as a promising treatment target for a condition with few options.

Catalog record

CREATORQingxian Zhang, Yonghong Shi, Jun Wada et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011709

Browse the full library · About the Tower of Babel